https://news.medxy.ai/zh/telehealth-stroke-recovery/Medxy AIzh2026-10-25T05:54:51-07:00远程医疗与可穿戴技术助力卒中后身体活动提升：一项可行性随机对照试验 https://news.medxy.ai/ja/telehealth-wearables-post-stroke-activity/Medxy AIja2026-10-25T05:54:32-07:00テレヘルスとウェアラブル技術で脳卒中後の身体活動を高める：実現可能性ランダム化比較試験 https://news.medxy.ai/vi/post-stroke-physical-activity/Medxy AIvi2026-10-25T05:54:03-07:00Tăng cường hoạt động thể chất sau đột quỵ bằng telehealth và công nghệ đeo: kết quả từ một thử nghiệm ngẫu nhiên có đối chứng khả thi https://news.medxy.ai/enhancing-post-stroke-physical-activity-through-telehealth-and-wearable-technology-a-feasibility-randomised-controlled-trial/Medxy AIen2026-10-25T05:53:36-07:00Enhancing Post-Stroke Physical Activity Through Telehealth and Wearable Technology: A Feasibility Randomised Controlled Trial https://news.medxy.ai/zh/advancing-dental-education/Medxy AIzh2026-10-25T05:52:58-07:00推进牙科教育：加拿大牙科学校缺损复合树脂修复体的修补与更换 https://news.medxy.ai/ja/canadian-dental-restoration-repair/Medxy AIja2026-10-25T05:52:28-07:00カナダ歯科教育の新潮流：不良コンポジットレジン修復物は修理か、交換か https://news.medxy.ai/vi/advancing-dental-education-2/Medxy AIvi2026-10-25T05:51:53-07:00Nâng tầm giáo dục nha khoa: Sửa chữa hay thay thế phục hồi composite khiếm khuyết tại các trường nha khoa Canada https://news.medxy.ai/advancing-dental-education-repair-versus-replacement-of-defective-composite-restorations-in-canadian-dental-schools/Medxy AIen2026-10-25T05:51:20-07:00Advancing Dental Education: Repair Versus Replacement of Defective Composite Restorations in Canadian Dental Schools https://news.medxy.ai/zh/yellow-fever-vaccine-dose-safety-immunogenicity/Medxy AIzh2026-10-25T05:50:34-07:00幼儿17DD黄热病疫苗分剂量接种的免疫原性与安全性：乌干达Ⅳ期随机试验及更广泛证据 https://news.medxy.ai/ja/yellow-fever-vaccine-trial/Medxy AIja2026-10-25T05:50:00-07:00幼児における17DD黄熱ワクチン分割接種の免疫原性と安全性：ウガンダ第4相無作為化試験とその位置づけ https://news.medxy.ai/vi/fractional-yellow-fever-vaccine-uganda/Medxy AIvi2026-10-25T05:49:22-07:00Vắc xin sốt vàng 17DD liều phân đoạn ở trẻ nhỏ: Bằng chứng từ thử nghiệm ngẫu nhiên pha 4 tại Uganda và bối cảnh mở rộng https://news.medxy.ai/immunogenicity-and-safety-of-fractional-17dd-yellow-fever-vaccine-doses-in-young-children-evidence-from-a-phase-4-randomised-trial-in-uganda-and-broader-context/Medxy AIen2026-10-25T05:48:50-07:00Immunogenicity and Safety of Fractional 17DD Yellow Fever Vaccine Doses in Young Children: Evidence from a Phase 4 Randomised Trial in Uganda and Broader Context https://news.medxy.ai/zh/pediatric-ventilation-feedback/Medxy AIzh2026-10-25T05:47:48-07:00实时反馈设备助力院前儿科通气质量提升：一项随机研究的启示 https://news.medxy.ai/ja/improving-pediatric-ventilation/Medxy AIja2026-10-25T05:47:20-07:00リアルタイムフィードバック装置で高める前病院小児換気の質：無作為化研究からの示唆 https://news.medxy.ai/vi/pediatric-ventilation-feedback-2/Medxy AIvi2026-10-25T05:46:42-07:00Nâng cao chất lượng thông khí nhi khoa trước bệnh viện bằng thiết bị phản hồi thời gian thực: Những phát hiện từ một nghiên cứu ngẫu nhiên https://news.medxy.ai/enhancing-prehospital-pediatric-ventilation-quality-with-real-time-feedback-devices-insights-from-a-randomized-study/Medxy AIen2026-10-25T05:46:17-07:00Enhancing Prehospital Pediatric Ventilation Quality with Real-Time Feedback Devices: Insights from a Randomized Study https://news.medxy.ai/zh/nerandomilast-pulmonary-fibrosis/Medxy AIzh2026-10-25T05:45:39-07:00nerandomilast有望减缓自身免疫性进行性肺纤维化：FIBRONEER-ILD试验带来新证据 https://news.medxy.ai/ja/nerandomilast-promising-results-in-autoimmune-ild/Medxy AIja2026-10-25T05:45:16-07:00自己免疫疾患関連の進行性肺線維症に対するnerandomilastに期待：FIBRONEER-ILD試験から見えた有望な結果 https://news.medxy.ai/vi/nerandomilast-slows-autoimmune-pulmonary-fibrosis/Medxy AIvi2026-10-25T05:44:52-07:00Nerandomilast cho thấy triển vọng làm chậm xơ phổi tiến triển trong bệnh tự miễn: Góc nhìn từ thử nghiệm FIBRONEER-ILD https://news.medxy.ai/nerandomilast-shows-promise-in-slowing-progressive-pulmonary-fibrosis-in-autoimmune-disease-insights-from-the-fibroneer-ild-trial/Medxy AIen2026-10-25T05:44:28-07:00Nerandomilast Shows Promise in Slowing Progressive Pulmonary Fibrosis in Autoimmune Disease: Insights from the FIBRONEER-ILD Trial https://news.medxy.ai/zh/long-term-proton-pump-inhibitors-after-lung-transplantation/Medxy AIzh2026-10-25T05:43:46-07:00肺移植后长期使用质子泵抑制剂：几乎人人都在用，但20年随访未见明确临床获益 https://news.medxy.ai/ja/long-term-ppi-after-lung-transplantation/Medxy AIja2026-10-25T05:43:19-07:00肺移植後の長期プロトンポンプ阻害薬使用：20年間でほぼ全例に及ぶも、臨床転帰の明確な改善は示されず https://news.medxy.ai/vi/long-term-proton-pump-inhibitors-lung-transplantation/Medxy AIvi2026-10-25T05:42:50-07:00Dùng thuốc ức chế bơm proton dài hạn sau ghép phổi: Gần như phổ biến tuyệt đối nhưng không thấy lợi ích rõ ràng trên kết cục lâm sàng trong hai thập kỷ https://news.medxy.ai/long-term-proton-pump-inhibitor-use-post-lung-transplantation-near-universal-but-no-clear-benefit-on-clinical-outcomes-over-two-decades/Medxy AIen2026-10-25T05:42:27-07:00Long-Term Proton Pump Inhibitor Use Post-Lung Transplantation: Near-Universal but No Clear Benefit on Clinical Outcomes Over Two Decades https://news.medxy.ai/zh/ivarmacitinib-palmoplantar-pustulosis/Medxy AIzh2026-10-25T05:41:40-07:00Ivarmacitinib 在掌跖脓疱病中展现快速且令人鼓舞的疗效与免疫调节作用：多中心临床试验启示 https://news.medxy.ai/ja/ivarmacitinib-pustulosis-palmaris-et-plantaris/Medxy AIja2026-10-25T05:41:17-07:00手掌足底膿疱症に対するIvarmacitinib：多施設試験が示した迅速な有効性と免疫リモデリングの可能性 https://news.medxy.ai/vi/ivarmacitinib-pustular-psoriasis/Medxy AIvi2026-10-25T05:40:46-07:00Ivarmacitinib cho thấy hiệu quả nhanh đầy hứa hẹn và điều hòa miễn dịch trong mụn mủ lòng bàn tay – lòng bàn chân: Góc nhìn từ một thử nghiệm lâm sàng đa trung tâm https://news.medxy.ai/ivarmacitinib-shows-promising-rapid-efficacy-and-immune-modulation-in-palmoplantar-pustulosis-insights-from-a-multicenter-clinical-trial/Medxy AIen2026-10-25T05:40:17-07:00Ivarmacitinib Shows Promising Rapid Efficacy and Immune Modulation in Palmoplantar Pustulosis: Insights from a Multicenter Clinical Trial https://news.medxy.ai/zh/awake-sedation-tap-block-liposuction/Medxy AIzh2026-10-25T05:39:34-07:00清醒镇静联合TAP block与肿胀麻醉在门诊脂肪抽吸联合腹壁整形术中的应用：一种安全有效的镇痛策略 https://news.medxy.ai/ja/pain-management-strategies/Medxy AIja2026-10-25T05:39:06-07:00鎮静・TAPブロック・ツメセント麻酔による日帰りリポアブドミノプラスティー：安全かつ有効な疼痛管理戦略 https://news.medxy.ai/vi/outpatient-abdominoplasty-pain-management/Medxy AIvi2026-10-25T05:38:39-07:00Phẫu thuật tạo hình thành bụng hút mỡ ngoại trú với an thần, TAP block và gây tê tumescent: chiến lược giảm đau an toàn và hiệu quả https://news.medxy.ai/outpatient-lipoabdominoplasty-using-sedation-tap-block-and-tumescent-anesthesia-a-safe-and-effective-pain-management-strategy/Medxy AIen2026-10-25T05:38:18-07:00Outpatient Lipoabdominoplasty Using Sedation, TAP Block, and Tumescent Anesthesia: A Safe and Effective Pain Management Strategy https://news.medxy.ai/zh/tele-icu-transfers/Medxy AIzh2026-10-25T05:37:35-07:00远程重症监护能力与重症 Medicare 患者跨院转运及潜在低价值转运的关联：全国性证据综合 https://news.medxy.ai/ja/remote-critical-care-transfers/Medxy AIja2026-10-25T05:37:05-07:00远程重症监护能力如何影响院际转运？——一项基于全国证据的系统综述 https://news.medxy.ai/vi/tele-icu-transfers-low-value-care/Medxy AIvi2026-10-25T05:36:35-07:00Chăm sóc hồi sức từ xa có liên quan gì đến chuyển viện giữa các bệnh viện và các ca chuyển viện có thể có giá trị thấp ở người bệnh Medicare nguy kịch? Bằng chứng tổng hợp toàn quốc https://news.medxy.ai/association-of-tele-critical-care-capability-with-interhospital-transfers-and-potentially-low-value-transfers-among-critically-ill-medicare-beneficiaries/Medxy AIen2026-10-25T05:36:03-07:00Association of Tele-Critical Care Capability With Interhospital Transfers and Potentially Low-Value Transfers Among Critically Ill Medicare Beneficiaries: A Nationwide Evidence Synthesis https://news.medxy.ai/zh/improving-clinic-care-experience/Medxy AIzh2026-10-25T05:35:08-07:00提升门诊照护体验：患者对环境式 AI 病历记录员的感受 https://news.medxy.ai/ja/ambient-ai-scribes-in-outpatient-care/Medxy AIja2026-10-25T05:34:46-07:00外来診療を支えるアンビエントAIスクライブ：患者はどう体験したか https://news.medxy.ai/enhancing-ambulatory-care-patient-experiences-with-ambient-ai-scribes/Medxy AIen2026-10-25T05:33:55-07:00Enhancing Ambulatory Care: Patient Experiences with Ambient AI Scribes https://news.medxy.ai/zh/midostaurin-venetoclax-aml/Medxy AIzh2026-10-25T05:33:21-07:00老年新诊断AML患者中米哚妥林联合低剂量阿糖胞苷与维奈克拉：INTERVENE II期试验的证据与启示 https://news.medxy.ai/ja/midostaurin-cytarabine-venetoclax-aml/Medxy AIja2026-10-25T05:32:47-07:00高齢の新規診断AMLに対するmidostaurin＋低用量シタラビン＋venetoclax：INTERVENE第2相試験からみたエビデンスと臨床的意義 https://news.medxy.ai/vi/87377-2-87377/Medxy AIvi2026-10-25T05:32:15-07:00Sử dụng midostaurin kết hợp với cytarabine liều thấp và venetoclax ở bệnh nhân cao tuổi mới được chẩn đoán mắc bệnh bạch cầu cấp dòng tủy (AML) https://news.medxy.ai/combining-midostaurin-with-low-dose-cytarabine-and-venetoclax-in-older-adults-with-newly-diagnosed-aml-evidence-and-implications-from-the-intervene-phase-2-trial/Medxy AIen2026-10-25T05:31:41-07:00Combining Midostaurin with Low-Dose Cytarabine and Venetoclax in Older Adults with Newly Diagnosed AML: Evidence and Implications from the INTERVENE Phase 2 Trial https://news.medxy.ai/zh/bronchiectasis-womens-health/Medxy AIzh2026-10-25T05:30:47-07:00支气管扩张症中的生育、妊娠与女性健康：来自多中心研究和全球患者调查的启示 https://news.medxy.ai/ja/bronchiectasis-pregnancy-health/Medxy AIja2026-10-25T05:30:22-07:00気管支拡張症女性の妊孕性・妊娠・健康を考える：多施設研究と国際患者調査からの知見 https://news.medxy.ai/vi/fertility-pregnancy-bronchiectasis/Medxy AIvi2026-10-25T05:29:52-07:00Khả năng sinh sản, thai kỳ và sức khỏe phụ nữ trong giãn phế quản: Góc nhìn từ nghiên cứu đa trung tâm và khảo sát bệnh nhân toàn cầu https://news.medxy.ai/fertility-pregnancy-and-womens-health-in-bronchiectasis-insights-from-a-multicenter-study-and-global-patient-survey/Medxy AIen2026-10-25T05:29:28-07:00Fertility, Pregnancy, and Women’s Health in Bronchiectasis: Insights from a Multicenter Study and Global Patient Survey https://news.medxy.ai/zh/intraocular-lens-power-calculation/Medxy AIzh2026-10-25T05:28:46-07:00超长眼人工晶状体屈光度计算优化：轴长校正与 AL/R 比值的作用 https://news.medxy.ai/vi/intraocular-lens-power-calculation-ar/Medxy AIvi2026-10-25T05:27:44-07:00Tối ưu hóa việc tính toán công suất thủy tinh thể nhân tạo cho mắt có trục nhãn cầu cực dài: Vai trò của việc hiệu chỉnh chiều dài trục nhãn cầu và tỷ số AL/R https://news.medxy.ai/optimizing-intraocular-lens-power-calculations-in-extremely-long-eyes-the-role-of-axial-length-adjustment-and-al-r-ratio/Medxy AIen2026-10-25T05:27:18-07:00Optimizing Intraocular Lens Power Calculations in Extremely Long Eyes: The Role of Axial Length Adjustment and AL/R Ratio https://news.medxy.ai/zh/idiopathic-unilateral-vestibulopathy/Medxy AIzh2026-10-25T05:26:36-07:00特发性急性单侧听前庭病的神经耳科与3D-FLAIR MRI相关性：推动诊断与机制认识 https://news.medxy.ai/ja/neurotologic-findings-and-mriorrelation/Medxy AIja2026-10-25T05:26:11-07:00特発性急性片側性聴前庭障害における神経耳科学的所見と3D-FLAIR MRIの関連：診断精度と病態理解の向上 https://news.medxy.ai/vi/idiopathic-unilateral-acute-vestibulopathy-mri/Medxy AIvi2026-10-25T05:25:34-07:00MRI 3D-FLAIR và dấu ấn thính thần kinh trong thính tiền đình cấp một bên vô căn: mở rộng chẩn đoán và hiểu biết https://news.medxy.ai/neurotologic-and-3d-flair-mri-correlates-in-idiopathic-acute-unilateral-audiovestibulopathy-advancing-diagnosis-and-understanding/Medxy AIen2026-10-25T05:25:10-07:00Neurotologic and 3D-FLAIR MRI Correlates in Idiopathic Acute Unilateral Audiovestibulopathy: Advancing Diagnosis and Understanding https://news.medxy.ai/zh/mesh-placement-matters/Medxy AIzh2026-10-25T05:24:28-07:00补片放置位置很关键：丹麦全国队列中择期切口疝修补术后的患者报告结局 https://news.medxy.ai/ja/postoperative-sensation-mesh-location/Medxy AIja2026-10-25T05:23:58-07:00メッシュの位置で変わる術後感覚：デンマーク全国コホートが示した切開ヘルニア修復後の患者報告アウトカム https://news.medxy.ai/vi/mesh-position-outcomes-incinerate/Medxy AIvi2026-10-25T05:23:26-07:00Vị trí đặt lưới có ý nghĩa: Kết cục do bệnh nhân báo cáo sau phẫu thuật sửa chữa thoát vị vết mổ theo kế hoạch trong một đoàn hệ toàn quốc tại Đan Mạch https://news.medxy.ai/mesh-position-matters-patient-reported-outcomes-after-elective-incisional-hernia-repair-in-a-danish-nationwide-cohort/Medxy AIen2026-10-25T05:22:59-07:00Mesh Position Matters: Patient-Reported Outcomes After Elective Incisional Hernia Repair in a Danish Nationwide Cohort https://news.medxy.ai/ja/maternal-choline-child-development/Medxy AIja2026-10-25T05:22:13-07:00妊娠中の母体ホスファチジルコリンと4歳までの児の行動・認知：ランダム化臨床試験 https://news.medxy.ai/vi/maternal-phosphatidylcholine-pregnancy-child-development/Medxy AIvi2026-10-25T05:21:32-07:00Phosphatidylcholine của mẹ trong thai kỳ và hành vi, nhận thức của trẻ đến 4 tuổi: Thử nghiệm lâm sàng ngẫu nhiên https://news.medxy.ai/prenatal-maternal-phosphatidylcholine-and-childrens-behavior-and-cognition-through-4-years-of-age-randomized-clinical-trial/Medxy AIen2026-10-25T05:21:02-07:00Prenatal Maternal Phosphatidylcholine and Children’s Behavior and Cognition through 4 Years of Age: Randomized Clinical Trial https://news.medxy.ai/zh/vascular-risk-factors-epilepsy/Medxy AIzh2026-10-25T05:20:15-07:00血管危险因素或是晚发性癫痫的重要推手：基于美国大型队列荟萃分析的新证据 https://news.medxy.ai/ja/vascular-risk-factors-late-onset-epilepsy/Medxy AIja2026-10-25T05:19:50-07:00血管性危険因子は晩発性てんかんの主要因か――米国大規模コホート統合解析から見えたこと https://news.medxy.ai/vi/vascular-risk-factors-2/Medxy AIvi2026-10-25T05:19:14-07:00Yếu tố nguy cơ mạch máu: tác nhân then chốt thúc đẩy động kinh khởi phát muộn trong một phân tích gộp quy mô lớn tại Hoa Kỳ https://news.medxy.ai/vascular-risk-factors-as-key-contributors-to-late-onset-epilepsy-insights-from-a-large-us-cohort-meta-analysis/Medxy AIen2026-10-25T05:18:47-07:00Vascular Risk Factors as Key Contributors to Late-Onset Epilepsy: Insights from a Large US Cohort Meta-Analysis https://news.medxy.ai/zh/setmelanotide-metabolic-risk/Medxy AIzh2026-10-25T05:17:59-07:00Setmelanotide 治疗可降低 POMC 或 LEPR 缺陷患者的代谢综合征风险 https://news.medxy.ai/ja/setmelanotide-reduces-metabolic-risk/Medxy AIja2026-10-25T05:17:33-07:00setmelanotide治療、POMC／LEPR欠損症患者のメタボリックシンドロームリスクを低減 https://news.medxy.ai/vi/setmelanotide-metabolic-syndrome-risk/Medxy AIvi2026-10-25T05:17:03-07:00Setmelanotide giúp giảm nguy cơ hội chứng chuyển hóa ở bệnh nhân thiếu hụt POMC hoặc LEPR https://news.medxy.ai/setmelanotide-therapy-reduces-metabolic-syndrome-risk-in-patients-with-pomc-or-lepr-deficiencies/Medxy AIen2026-10-25T05:16:40-07:00Setmelanotide Therapy Reduces Metabolic Syndrome Risk in Patients with POMC or LEPR Deficiencies https://news.medxy.ai/zh/sst2-fulminant-myocarditis-mechanism/Medxy AIzh2026-10-25T05:15:59-07:00揭示 sST2 在暴发性心肌炎中的致病作用：一种新的线粒体治疗轴 https://news.medxy.ai/sst2-myocarditis-treatment/Medxy AIen2026-10-25T05:14:27-07:00Unraveling sST2’s Role in Fulminant Myocarditis: A Novel Mitochondrial Therapeutic Axis https://news.medxy.ai/zh/early-quadriceps-strength-recovery-predicts-2-year-outcomes/Medxy AIzh2026-10-25T05:13:39-07:00采用自体股四头肌腱移植进行前交叉韧带重建术后，股四头肌肌力的早期恢复可预测术后2年的预后结果 https://news.medxy.ai/ja/early-quadriceps-strength-recovery-predicts-outcomes-after-quadriceps-tendon-autograft-acl-reconstruction/Medxy AIja2026-10-25T05:13:10-07:00自家大腿四頭筋腱を用いたACL再建術後2年における転帰の予測因子としての、大腿四頭筋筋力の早期回復 https://news.medxy.ai/vi/early-quadriceps-strength-predicts-acl-outcomes/Medxy AIvi2026-10-25T05:12:33-07:00Phục hồi sớm sức mạnh cơ tứ đầu đùi dự báo kết cục sau 2 năm sau tái tạo ACL bằng mảnh ghép tự thân gân cơ tứ đầu đùi https://news.medxy.ai/early-quadriceps-strength-recovery-predicts-2-year-outcomes-after-quadriceps-tendon-autograft-acl-reconstruction/Medxy AIen2026-10-25T05:12:00-07:00Early Quadriceps Strength Recovery Predicts 2-Year Outcomes After Quadriceps Tendon Autograft ACL Reconstruction https://news.medxy.ai/vi/soft-tissue-augmentation-dental-implants/Medxy AIvi2026-10-25T05:11:55-07:00Đánh giá tăng cường mô mềm trong cấy ghép nha khoa thẩm mỹ: Ghép mô liên kết hay màng collagen ổn định thể tích https://news.medxy.ai/zh/soft-tissue-augmentation-choices/Medxy AIzh2026-10-25T05:11:02-07:00美学种植中的软组织增量如何选择：结缔组织移植与稳定体积胶原基质的比较 https://news.medxy.ai/ja/soft-tissue-augmentation-in-implant-treatment/Medxy AIja2026-10-25T05:10:38-07:00審美的インプラント治療における軟組織増大の評価：結合組織移植片と厚み安定性コラーゲンマトリックスの比較 https://news.medxy.ai/ja/balance-and-dizziness-improvement/Medxy AIja2026-10-25T05:10:35-07:00慢性末梢性前庭機能障害におけるバランス改善とめまい軽減：反復経頭蓋磁気刺激の役割 https://news.medxy.ai/enhancing-balance-and-reducing-dizziness-in-chronic-peripheral-vestibular-dysfunction-the-role-of-repetitive-transcranial-magnetic-stimulation/Medxy AIen2026-10-25T05:09:51-07:00Enhancing Balance and Reducing Dizziness in Chronic Peripheral Vestibular Dysfunction: The Role of Repetitive Transcranial Magnetic Stimulation https://news.medxy.ai/evaluating-soft-tissue-augmentation-in-aesthetic-implant-dentistry-connective-tissue-graft-versus-volume-stable-collagen-matrix/Medxy AIen2026-10-25T05:09:30-07:00Evaluating Soft-Tissue Augmentation in Aesthetic Implant Dentistry: Connective Tissue Graft Versus Volume-Stable Collagen Matrix https://news.medxy.ai/zh/repetitive-magnetic-stimulation-for-vertigo/Medxy AIzh2026-10-25T05:09:06-07:00慢性外周前庭功能障碍的平衡改善与眩晕减轻：经颅重复磁刺激的作用 https://news.medxy.ai/zh/acute-kidney-replacement-therapy/Medxy AIzh2026-10-25T05:08:42-07:00急性肾损伤中间歇性与连续肾脏替代治疗：来自多中心试验的启示 https://news.medxy.ai/ja/intermittent-vs-continuous-dialysis/Medxy AIja2026-10-25T05:08:17-07:00急性腎障害における間欠的治療と持続的腎代替療法：多施設試験から見えたもの https://news.medxy.ai/vi/intermittent-vs-continuous-dialysis-2/Medxy AIvi2026-10-25T05:07:45-07:00Thay thế thận ngắt quãng hay liên tục trong tổn thương thận cấp: Những phát hiện từ một thử nghiệm đa trung tâm https://news.medxy.ai/intermittent-vs-continuous-renal-replacement-therapy-in-acute-kidney-injury-insights-from-a-multicenter-trial/Medxy AIen2026-10-25T05:07:20-07:00Intermittent vs Continuous Renal-Replacement Therapy in Acute Kidney Injury: Insights from a Multicenter Trial